NCT05594303View on ClinicalTrials.gov

COPD Treatment by Transplantation of Autologous Bronchial Basal Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 27, 2019

Primary Completion Date

May 16, 2022

Study Completion Date

November 18, 2022

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
BIOLOGICAL

Autologuos transplantation of bronchial basal cells

Autologuos transplantation of bronchial basal cells

Trial Locations (1)

510000

Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
collaborator

Regend Therapeutics

INDUSTRY

lead

Guangzhou Institute of Respiratory Disease

OTHER

NCT05594303 - COPD Treatment by Transplantation of Autologous Bronchial Basal Cells | Biotech Hunter | Biotech Hunter